June 27, 2019 PR/Corporate

Moody’s Upgrades Bio-Rad to Baa2, Reflecting Recent Improvement in the Company’s Operating Performance

HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced that Moody’s Investors Service (“Moody’s”) upgraded the unsecured rating of Bio-Rad Laboratories, Inc. senior unsecured notes to Baa2 from Baa3. The outlook was changed to stable from positive. According to Moody’s, the upgrade reflects recent... Read more

June 27, 2019 Life Science Tools PR/Corporate

Danaher Announces New Dental Company To Be Named Envista Holdings Corporation

WASHINGTON, June 27, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) today announced that Envista Holdings Corporation (“Envista” or the “Company”) will be the name of the separate company Danaher intends to create and take public via an initial public offering in the second half of 2019.  Envista will be comprised of three operating companies within... Read more

June 26, 2019 PR/Corporate

Bio-Techne China Recognized With “Decade of Contribution Award”

JUNE 26, 2019 MINNEAPOLIS, June 26, 2019 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) was recently honored with the “Decade of Contribution Award” at the 2019 (10th) International Conference on Cell Therapy conference. This award recognized the commitment of Bio-Techne’s team in China to providing comprehensive support and reliable products and services for the Chinese Biotechnology industry. The 2019 (10th) International... Read more

June 26, 2019 PAI Top-10 PR/Corporate

We have posted "Financial Results Presentation".

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more

June 25, 2019 PR/Corporate

Bio-Techne Appoints Rupert Vessey to Board of Directors

JUNE 25, 2019 MINNEAPOLIS, June 25, 2019 /PRNewswire/ — Bio-Techne Corporation today announced the appointment of Dr. Rupert Vessey to the company’s Board of Directors as an independent director.  Dr. Vessey’s appointment brings the total number of Bio-Techne Board members to nine. Rupert Vessey, MA, BM BCh, FRCP, DPhil is currently the President of Global Research... Read more

June 20, 2019 Lab Top-10 PR/Corporate

MilliporeSigma, EMD Serono and EMD Performance Materials make prestigious Massachusetts top employer list for 2019

20 JUN 2019 | BURLINGTON, MASSACHUSETTS, UNITED STATES OF AMERICA Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that its Massachusetts-based business sectors, MilliporeSigma, EMD Serono and EMD Performance Materials, have been named to the Boston Business Journal’s annual “Best Places to Work” list. Companies were selected based on survey responses provided by employees.... Read more

June 20, 2019 Clinical Research/Diagn. PR/Corporate

Steven Daniel joins Cofactor Genomics as Vice President of Business Development

— Leading Cofactor’s commercial efforts to grow the Predictive Immune Modeling market   — San Francisco, June 20, 2019 (REPORTABLE) — Cofactor Genomics today announced the appointment of Steven Daniel, PhD as Vice President of Business Development, overseeing the development and execution of the company’s sales strategy and sales management. Dr. Daniel comes to Cofactor from... Read more

June 20, 2019 Lab Top-10 PR/Corporate Product Launch

Bruker Launches MALDI Biotyper Sirius at ASM Microbe Conference

– Introduction of new MALDI Biotyper sirius™ system with additional negative-ion mode to support MALDI research and RUO validation studies, e.g. for colistin-resistance testing – US introduction of Micronaut™ products for true minimum inhibitory concentration (MIC) antibiotic susceptibility testing (AST) in veterinary medicine – US introduction of RUO versions of MALDI Biotyper-based rapid Selective-Testing of... Read more

June 19, 2019 PR/Corporate

Greiner Bio-One looks back on a solid financial year 2018

Rainer Perneker, CEO Greiner Bio-One International GmbH, Credit Greiner AG Kremsmünster, May 2019 – Owing to continuing high demand and use of capacity in the core segments, both Greiner Bio-One and its suppliers invested significant sums in the enlargement of global production. The bulk of an investment volume of EUR 44.8 million flowed into new... Read more